197
Participants
Start Date
June 19, 2018
Primary Completion Date
September 14, 2020
Study Completion Date
August 17, 2021
BMS-986036
Specified dose on specified days.
Placebo
Specified dose on specified days.
Local Institution - 0083, New York
Local Institution - 0038, New York
Icahn School of Medicine at Mount Sinai, New York
Local Institution - 0078, Manhasset
University at Buffalo, Buffalo
Local Institution - 0006, Pittsburgh
University of Pennsylvania, Philadelphia
Local Institution - 0009, Philadelphia
MedStar Georgetown University Hospital, Washington D.C.
Gastroenterology Associates, PC, Manassas
The Gastroenterology Group, Reston
Local Institution - 0007, Baltimore
Local Institution - 0057, Catonsville
Inova Fairfax Hospital, Falls Church
University of Virginia Health System, Charlottesville
Bon Secours Liver Institute of Richmond, Richmond
Local Institution - 0077, Richmond
Local Institution - 0049, Richmond
Local Institution - 0069, Norfolk
Local Institution - 0096, Concord
Local Institution - 0064, Charlotte
Local Institution - 0105, Marietta
Local Institution - 0082, Jacksonville
Local Institution - 0100, Gainesville
Local Institution - 0081, Orlando
Clinical Research of Homestead, Homestead
Local Institution - 0079, Coral Gables
Local Institution - 0002, Miami
A+ Research, Miami
IMIC Research, Miami
Top Medical Research, Cutler Bay
Tampa General Hospital, Tampa
Local Institution - 0003, Lakewood Rch
Sensible Healthcare, Ocoee
Local Institution - 0087, Madison
Local Institution - 0041, Hermitage
Local Institution - 0047, Germantown
University of Michigan, Ann Arbor
Local Institution - 0063, Chesterfield
Saint Louis University, St Louis
Saint Lukes Hospital of Kansas City, Kansas City
Tandem Clinical Research, Marrero
Tulane University Health Sciences Center, New Orleans
Local Institution - 0027, New Orleans
Local Institution - 0053, Dallas
Local Institution - 0052, Dallas
Texas Digestive Disease Consultants - Dallas, Dallas
Texas Clinical Research Institute, Arlington
Texas Digestive Disease Consultants - Southlake, Fort Worth
Local Institution - 0004, Houston
Local Institution - 0059, Houston
Local Institution - 0062, Houston
Local Institution - 0029, San Antonio
Local Institution - 0012, San Antonio
Local Institution - 0101, San Antonio
Local Institution - 0066, Austin
Local Institution - 0088, Phoenix
Local Institution - 0001, Phoenix
Local Institution - 0005, Chandler
The Institute for Liver Health - Tucson, Tucson
Local Institution - 0017, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Huntington Medical Research Institutes - HMRI Liver Center, Pasadena
Local Institution - 0019, Pasadena
Catalina Research Institute, Montclair
University of California San Diego, La Jolla
Local Institution - 0092, Coronado
Medical Associates Research Group, San Diego
Local Institution - 0013, Rialto
Local Institution - 0089, San Clemente
Kindred Medical Institute for Clinical Trials, Corona
Local Institution - 0044, Oxnard
Local Institution - 0074, Redwood City
Local Institution - 0068, San Francisco
Local Institution - 0008, Oakland
Keio University Hospital, Shinjuku-ku
Local Institution - 0072, Kashihara
Kurume University Hospital, Kurume
GastroIntestinal Biosciences, Los Angeles
Bridgeport Hospital, Bridgeport
Boston Medical Center, Boston
NECCR PrimaCare Research, Fall River
Local Institution - 0067, Butner
Vanderbilt University Medical Center, Nashville
University of Texas Southwestern Medical Center, Dallas
University of Vermont Medical Center, Burlington
Local Institution - 0056, Yokohama
Toranomon Hospital, Minato
Fukushima Medical University Hospital, Fukushima
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY